Engineering chimeric PCSK9 for a vaccine against atherosclerosis
Špela Malenšek(University of Ljubljana), Roman Jerala(National Institute of Chemistry), Hana Esih(University of Ljubljana), Duško Lainšček(National Institute of Chemistry), Anja Golob Urbanc(National Institute of Chemistry), Sara Orehek(University of Ljubljana), Aleš Blinc(University of Ljubljana), Tina Fink(National Institute of Chemistry)
Cited by 3
Related Papers
Similarities and Specificities of Fungal Keratinolytic Proteases: Comparison of Keratinases of <i>Paecilomyces marquandii</i> and <i>Doratomyces microsporus</i> to Some Known Proteases
|Applied and Environmental Microbiology|2005|231
NLRP3 lacking the leucine-rich repeat domain can be fully activated via the canonical inflammasome pathway
|Nature Communications|2018|137
Disruption of disulfides within RBD of SARS‐CoV‐2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs
|The FASEB Journal|2021|62
Cellular reprogramming in farm animals: an overview of iPSC generation in the mammalian farm animal species
|Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology|2016|52
The primary structure of inhibitor of cysteine proteinases from potato
|FEBS Letters|1993|44